Evaluation of the Impact of a HPV Vaccination Talk with Third Grade Students

NCT ID: NCT06631794

Last Updated: 2024-10-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

1170 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-10-23

Study Completion Date

2025-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a prospective pragmatic study to assess the impact of a HPV vaccination talk in secondary school on actual vaccine dispensing in test communes compared with control communes. The talk consist on a briefing on the importance of vaccination.

This is a controlled study, since two communes will benefit from the HPV vaccination talk, while the other two will serve as controls without set up of the HPV vaccination talk. The set up of this presentation will be open-label.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The main aim of the present study is to investigate the impact of HPV vaccination talk with 3rd grade school children on HPV vaccine dispensing by making them actors in their own health. A significant benefit on vaccination coverage is expected. In addition, a flyer providing information and raising awareness of infections and the benefits of HPV vaccination will be sent to parents at the end of the talk.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Teenagers

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

A short talk about the importance of HPV vaccination

Investigator plan to set up a short talk to 3rd grade classes in addition to the usual sexual health training. The issue of HPV vaccination will be systematically addressed for 10 minutes to encourage catch-up vaccination.

The usual training include different themes such us : definition of sexual health, anatomy, sexually transmitted infections contraception/condoms, menstrual cycles, voluntary interruption of pregnancy, consent, sexual abuse/violence/harassment, pornography, anti-discrimination....

A 45-minute talk will include 2 or 3 topics from the above list. A ten minutes of talk will be added to the usual training to explain the HPV vaccination (a topic not usually addressed in sexual health training), covering the following elements: definition of HPV infection

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 3rd grade students enrolled in public secondary schools in Suresnes and Rueil-Malmaison.

Exclusion Criteria

* Students absent on the day of the talk.
* Students unwilling/unable to complete questionnaire.
Minimum Eligible Age

14 Years

Maximum Eligible Age

14 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Agence Regionale de Sante d'Ile de France

UNKNOWN

Sponsor Role collaborator

Ospharm coopérative

UNKNOWN

Sponsor Role collaborator

French Interregional Group of Clinical Research and Innovation

OTHER

Sponsor Role collaborator

Communauté professionnelle territoriale de santé

UNKNOWN

Sponsor Role collaborator

Hopital Foch

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

David Zuckman, Doctor

Role: CONTACT

0146252093

Kewin KP Panel, Master

Role: CONTACT

0146253576

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023_0258

Identifier Type: OTHER

Identifier Source: secondary_id

2023_0258

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Video to Promote HPV Vaccination
NCT02196454 COMPLETED NA
SDH of HPV Vaccine Completion
NCT03709602 COMPLETED
PREVENT HPV -Related Cancers Trial
NCT07217145 RECRUITING NA